Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, published results of a proteomics ...

There are few scientific methods more elegantly simple than "just sprinkle it on top." Researchers at Tohoku University and ...

A team of researchers has discovered that a protein called cypin plays a powerful role in helping brain cells connect and ...

The potential for these kinds of machines to reshape computer processing, increase energy efficiency, and revolutionize ...

The brain remains highly active during sleep, and mapping this activity can reveal early signs of neurological and sleep ...

The research team found that different parts of the Dystroglycan protein are responsible for synapse development. The outer part of the protein is necessary to build synapses while the inner part, ...

Rutgers researchers discovered that the brain protein cypin strengthens synaptic connections crucial for memory and learning.

Researchers at Leipzig University’s Carl Ludwig Institute have discovered that in the cerebral cortex, synaptic signal ...

UB researchers are taking inspiration from the human brain to develop computing architecture that can support the growing ...

Silent synapses are dormant neural connections that hold untapped brain potential. ... AMPA-silent synapses in brain development and pathology. Nature Reviews Neuroscience, 14(12), 839-850.

At the time of the Gate-Boost deal, Südhof said Boost’s proprietary platform was designed to develop drugs to promote the health of synapses and treat a wide array of central nervous system ...